Amylyx Pharmaceuticals Inc (AMLX)

[Whalatane]

Well good to see you're still here Ernie

• Phase 3 LUCIDITY trial underway. Began dosing in April 2025
and data readout anticipated in 1H 2026
• FDA-agreed upon primary outcome of reduction in
hypoglycemic events

I think this Co will also be closely watching the P3 results due in Dec for RZLT
JMO
Kiwi